rephrase: This would involve analyzing the blood or urine for specific biomarkers associated with renal interstitial fibrosis [NAME_1 et NAME_2.] or using sweat sensors to measure metabolites [Sempionatto et NAME_2.]. MicroRNAs have also been identified as potential biomarkers for chronic kidney disease [NAME_3 et NAME_2.]. 